Cargando…
Safety, efficacy, and patient selection of ripasudil in patients with uncontrolled glaucoma with maximum conventional medical therapy
PURPOSE: Ripasudil hydrochloride hydrate (0.4%) is the first Rho-associated protein kinase (ROCK) inhibitor eye drop that lowers intraocular pressure (IOP) by increasing conventional aqueous outflow through the trabecular meshwork and Schlemm’s canal. We aimed to evaluate the safety and efficacy of...
Autores principales: | Jethva, Jignesh, Bhagat, Purvi, Prajapati, Kamini, Tank, Gunjan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359231/ https://www.ncbi.nlm.nih.gov/pubmed/35647972 http://dx.doi.org/10.4103/ijo.IJO_3145_21 |
Ejemplares similares
-
Favorable effect of ripasudil use on surgical outcomes of microhook ab interno trabeculotomy
por: Okuda, Mina, et al.
Publicado: (2023) -
Increase in the OCT angiographic peripapillary vessel density by ROCK inhibitor ripasudil instillation: a comparison with brimonidine
por: Chihara, Etsuo, et al.
Publicado: (2018) -
Rhino-orbital-cerebral mucormycosis: An epidemiological study from a tertiary care referral center in Western India
por: Patel, Ravija, et al.
Publicado: (2022) -
Correlation between choroidal thickness and intraocular pressure control in primary angle-closure glaucoma
por: Singh, Nishtha, et al.
Publicado: (2022) -
Validating the use of U-tool as a novel method for measuring the corneal diameter in infants screened for congenital glaucoma
por: Bafna, Rahul Kumar, et al.
Publicado: (2022)